Negative selection in hepatic tumor promotion in relation to cancer risk assessment
- 1 September 1995
- journal article
- review article
- Published by Elsevier in Toxicology
- Vol. 102 (1-2) , 223-237
- https://doi.org/10.1016/0300-483x(95)03051-g
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Carbon Tetrachloride Suppresses T-Cell-Dependent Immune Responses by Induction of Transforming Growth Factor-1Toxicology and Applied Pharmacology, 1994
- Computer Simulation of Cell Growth Governed by Stochastic Processes: Application to Clonal Growth Cancer ModelsToxicology and Applied Pharmacology, 1994
- Inactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β ActivitiesScience, 1993
- Modeling Receptor‐Mediated Processes with Dioxin: Implications for Pharmacokinetics and Risk AssessmentRisk Analysis, 1993
- cDNA cloning and structure of mouse putative Ah receptorBiochemical and Biophysical Research Communications, 1992
- The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locusNature, 1991
- TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDDToxicology and Applied Pharmacology, 1990
- Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxinArchives of Toxicology, 1988
- Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effectBritish Journal of Cancer, 1983
- Models of Carcinogenesis as an Escape from Mitotic InhibitorsScience, 1976